Vanguard Group’s Rani Therapeutics RANI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $411K | Hold |
799,679
| – | – | ﹤0.01% | 3964 |
|
|
2025
Q1 | $1.01M | Buy |
799,679
+89,851
| +13% | +$113K | ﹤0.01% | 3707 |
|
|
2024
Q4 | $972K | Hold |
709,828
| – | – | ﹤0.01% | 3777 |
|
|
2024
Q3 | $1.53M | Hold |
709,828
| – | – | ﹤0.01% | 3639 |
|
|
2024
Q2 | $2.7M | Buy |
709,828
+24,525
| +4% | +$93.2K | ﹤0.01% | 3470 |
|
|
2024
Q1 | $2.13M | Buy |
685,303
+16,956
| +3% | +$52.7K | ﹤0.01% | 3572 |
|
|
2023
Q4 | $2.22M | Sell |
668,347
-742
| -0.1% | -$2.46K | ﹤0.01% | 3562 |
|
|
2023
Q3 | $1.46M | Hold |
669,089
| – | – | ﹤0.01% | 3698 |
|
|
2023
Q2 | $2.76M | Hold |
669,089
| – | – | ﹤0.01% | 3560 |
|
|
2023
Q1 | $3.45M | Hold |
669,089
| – | – | ﹤0.01% | 3475 |
|
|
2022
Q4 | $3.95M | Buy |
669,089
+18,111
| +3% | +$107K | ﹤0.01% | 3416 |
|
|
2022
Q3 | $6.24M | Buy |
650,978
+317,849
| +95% | +$3.04M | ﹤0.01% | 3208 |
|
|
2022
Q2 | $3.44M | Buy |
333,129
+43,022
| +15% | +$444K | ﹤0.01% | 3558 |
|
|
2022
Q1 | $3.92M | Buy |
290,107
+4,561
| +2% | +$61.6K | ﹤0.01% | 3644 |
|
|
2021
Q4 | $4.67M | Buy |
285,546
+2,333
| +0.8% | +$38.1K | ﹤0.01% | 3653 |
|
|
2021
Q3 | $5.05M | Buy |
+283,213
| New | +$5.05M | ﹤0.01% | 3658 |
|